Simplexa C. difficile Direct and 1 more
C. Difficile Toxin Gene Amplification Assay. 510(k) K163085, from Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC (Cypress, CA). Product code OZN, class 2.
As of Nov 21, 2026, K163085 is an FDA 510(k) held by Focus Diagnostics, Inc.:Dba Diasorin Molecular, LLC, substantially equivalent on Feb 14, 2017 after 103 days, with no recalls tied to it in FDA's recall database.
- Review time: 103 days
- Recalls: 0
Simplexa C. difficile Direct The Focus Diagnostics Simplexa™ C. difficile Direct assay is intended for use on the Integrated Cycler instrument for the detection of Clostridium difficile toxin B gene (tcdB) present in liquid or unformed stool samples from individuals suspected of C. difficile infection (CDI). This test aids in the diagnosis of illness resulting from CDI.
- BD Max Cdiff Assay, BD Max InstrumentK130470 · Geneohm Sciences Canada, Inc. (Bd Diagnostics) · Apr 2, 2013
- cobas® Cdiff Nucleic acid test for use on the cobas® Liat® System (07454945190); cobas® Cdiff Positive and Negative…K260045 · Roche Molecular Systems, Inc. · Aug 28, 2026
- Xpert C. difficile/EpiK243730 · Cepheid® · Feb 28, 2025
- Great Basin Toxigenic C. difficile Direct Test (CDF2)K232092 · Vela Operations USA · Nov 14, 2023
- cobas Cdiff nucleic acid test for use on the cobas Liat SystemK212427 · Roche Molecular Systems, Inc. · Oct 20, 2021
- cobas Cdiff nucleic acid test for use on the cobas Liat SystemK210385 · Roche Molecular Systems, Inc. · Sep 9, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 3, 2016
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3130
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files